Female Pattern Hair Loss vs Telogen Effluvium: How to Tell the Difference

When a woman notices her hair thinning, one of the most important questions — and one of the least often answered clearly — is what type of hair loss she is dealing with. The two most common forms of hair loss in women look similar on the surface: both cause thinning, both cause increased daily shedding, and both can occur at any age. But they have completely different causes, different patterns, different timelines, and require different approaches. Treating one as if it were the other produces poor results and wasted time.

Female pattern hair loss (FPHL) — also called androgenetic alopecia — is a genetic condition in which follicles at the crown and parting are sensitive to androgens and progressively miniaturise over time. It is chronic and slowly progressive. Telogen effluvium (TE) is a different process entirely: a systemic disruption that pushes a large proportion of follicles into the resting (telogen) phase simultaneously, causing sudden and often dramatic shedding. TE is typically triggered by a specific event — illness, surgery, postpartum hormonal shift, nutritional deficiency, or prolonged stress — and in most cases resolves once the trigger is addressed.

Many women have both. FPHL creates a background of gradual thinning that a TE episode can then accelerate dramatically, making the total loss appear sudden even when the underlying pattern hair loss had been developing quietly for years. This overlap is part of why both conditions are frequently misdiagnosed.

This article explains how to distinguish the two, what each one means for your hair over time, and how homecare fits into managing both. For the broader context of hormonal drivers behind both conditions, see our article on hormonal hair loss in women.

This article is for educational purposes and does not constitute medical advice. A dermatologist or trichologist can provide a clinical diagnosis through scalp examination and, where needed, a biopsy or trichoscopy.

Quick Answer

Female pattern hair loss causes slow, progressive thinning concentrated at the crown and parting — driven by androgen sensitivity and genetic predisposition. Telogen effluvium causes sudden, diffuse shedding across the entire scalp triggered by a systemic event 2–3 months prior. FPHL is chronic and does not self-resolve. TE is typically temporary and reverses once the trigger is removed, though recovery takes 6–12 months. Both are supported by daily scalp homecare that improves the follicle environment — though the medical approach to each is different.

Understanding Each Condition

Female Pattern Hair Loss (FPHL)

FPHL is the most common cause of hair loss in women and can begin as early as the 20s or 30s, though it is more prevalent and more visible after the menopause transition when oestrogen no longer provides its protective effect on the follicle. The underlying mechanism is androgen sensitivity: follicles at the crown and parting have receptors that respond to DHT by progressively miniaturising — producing shorter, finer hairs with each successive cycle until eventually the cycle stops producing visible hair at all.

The pattern is characteristically different from male hair loss. Women with FPHL typically see a widening of the central parting and diffuse thinning at the crown, while the frontal hairline remains largely intact. The Ludwig classification describes three stages of severity. Daily shedding in FPHL is typically not dramatically elevated — the loss is cumulative over years, not sudden.

Telogen Effluvium (TE)

Telogen effluvium occurs when a systemic disruption pushes an abnormally high proportion of follicles — sometimes 30% or more — simultaneously into the telogen (resting) phase. After the standard 3–4 month telogen duration, these follicles shed en masse. The trigger is typically something that happened 2–3 months before the visible shedding: a significant illness, major surgery, childbirth, a crash diet, severe nutritional deficiency, or a prolonged period of high stress.

The shedding pattern is diffuse — thinning occurs evenly across the whole scalp rather than concentrated at the crown or parting. Daily shed counts are noticeably elevated: women with acute TE often describe finding hair everywhere and losing far more than the normal 50–100 hairs per day. The American Academy of Dermatology notes that acute TE typically resolves within 6 months of the trigger being removed, though chronic TE — where the underlying trigger persists — can last longer.

Comparing the Two Conditions

What Actually Helps Each Condition

For Female Pattern Hair Loss

FPHL requires ongoing management because the androgen sensitivity driving it does not resolve. Medical options include topical minoxidil and, in some women, anti-androgen therapies prescribed by a dermatologist. Daily scalp homecare with a phyto-exosome ampoule supports the follicle environment, calms the scalp inflammation that accelerates miniaturisation, and provides growth factor signalling that helps maintain the follicles that are still active. It is a complementary daily layer, not a standalone treatment for established FPHL. The earlier it is started, the more follicles there are to support.

For Telogen Effluvium

For acute TE, the primary intervention is removing or addressing the trigger: resolving nutritional deficiencies (ferritin is the most common), managing the stress load, allowing the body to recover from illness or surgery. Once the trigger is resolved, the follicles will naturally re-enter the anagen phase — but recovery takes time. A daily scalp ampoule during the recovery period supports the quality of the returning growth and the scalp conditions that influence how quickly follicles re-enter the growth phase. For the full explanation of how this recovery unfolds, see our article on what to realistically expect from a hair growth ampoule.

Frequently Asked Questions

Can I have both FPHL and telogen effluvium at the same time?

Yes — and this is more common than most people realise. FPHL creates a background of slow progressive thinning. A TE episode then accelerates the visible loss dramatically, making it appear sudden even though the underlying pattern hair loss had been present for some time. The combination makes diagnosis more complex and is one reason clinical assessment is important: treating only the TE while FPHL continues untreated will result in partial recovery at best.

How much shedding is normal vs telogen effluvium?

Losing 50–100 hairs per day is within the normal range for most people. TE typically produces significantly more — many women describe 200–400 hairs per day or more during a peak episode, noticing hair everywhere: on pillows, in shower drains, on clothing. If your daily shed count has clearly elevated beyond your personal normal and you can identify a likely trigger 2–3 months prior, TE is the probable cause.

Does FPHL cause scalp itching or discomfort?

Mild scalp sensitivity and irritation are sometimes associated with FPHL — likely related to the chronic low-grade inflammation that accompanies follicle miniaturisation. It is not the dominant symptom, but it is not uncommon. Scalp discomfort is more often associated with scalp conditions like seborrhoeic dermatitis, which can co-exist with and accelerate FPHL. Addressing scalp inflammation through daily homecare benefits both.

How long does telogen effluvium last?

Acute TE typically peaks around 3–4 months after the trigger and resolves within 6 months once the trigger is removed. Recovery — full regrowth to pre-TE density — can take a further 6–12 months as the re-entered follicles produce new growth that lengthens progressively. Chronic TE, where the underlying trigger persists (ongoing stress, unresolved nutritional deficiency, thyroid disorder), can last much longer and requires addressing the root cause.

Do I need a biopsy to diagnose which type I have?

Not always. An experienced dermatologist or trichologist can often distinguish FPHL from TE through scalp examination, trichoscopy (dermoscopy of the scalp), and clinical history alone. A scalp biopsy is reserved for ambiguous cases or when other diagnoses need to be excluded. Blood tests are important in both cases to identify any correctable underlying cause.

Is daily scalp treatment helpful for both conditions?

Yes. In FPHL, daily scalp homecare supports the follicle environment that determines the rate of miniaturisation — anti-inflammatory actives slow the process and phyto-exosomes support the follicles still in active production. In TE, daily scalp care during and after the episode supports the quality of regrowth and the scalp conditions that govern how quickly follicles re-enter the growth phase. The mechanism is complementary to medical treatment in both cases.

The Bottom Line

Female pattern hair loss and telogen effluvium look similar but are fundamentally different conditions requiring different approaches. FPHL is chronic, progressive, and androgen-driven — it requires ongoing management. TE is triggered, temporary, and diffuse — it requires identifying and removing the cause. Many women have both simultaneously. Getting the diagnosis right — through clinical assessment, blood tests, and trichoscopy if needed — is the foundation of effective management.

Daily scalp homecare that supports the follicle environment benefits both conditions. For the complete overview of female hair loss in Singapore, see our complete guide to hair loss in women. For the hormonal drivers behind both conditions, read our article on hormonal hair loss in women.

Take the Next Step

elihe’s AmpliHair Hair Growth Ampoule supports the scalp environment daily — reducing follicle inflammation, delivering growth factor signals, and creating the conditions for healthy hair cycling whether you are managing FPHL, recovering from TE, or both.

Featured by Singapore Airlines SilverKris · Business Traveller Magazine · Winner: Best Hair Growth & Strengthening Ampoule — Editors’ Choice Award · 100% drug-free